Pulmonx Corporation Common Stock
Symbol: LUNG (NASDAQ)
1.62
▲ (1.64%) 0.026
Company Description:
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
Key Stats
- Today's Open: $1.6
- Today's High: $1.665
- Today's Low: $1.585
- Today's Volume: 167.88K
- Yesterday Close: $1.59
- Yesterday High: $1.61
- Yesterday Low: $1.56
- Yesterday Volume: 147.85K
- Last Min Volume: 0
- Last Min High: $1.636
- Last Min Low: $1.616
- Last Min VWAP: $0
Company Profile
- Name: Pulmonx Corporation Common Stock
- Website: https://www.pulmonx.com
- Listed Date: 2020-10-01
- Location: REDWOOD CITY, CA
- Market Status: Active
- CIK Number: 0001127537
- SIC Code: 3841
- SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Market Cap: $66.82M
- Round Lot: 100
- Outstanding Shares: 40.75M
- Asset Type: CS
RECENT FILINGS FOR LUNG
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-26 | S-3 | View |
| 2025-09-08 | SCHEDULE 13G/A | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-08-06 | SCHEDULE 13G/A | View |
| 2025-08-01 | 10-Q | View |
| 2025-07-30 | 8-K | View |
| 2025-06-13 | 4 | View |
| 2025-06-13 | 144 | View |
| 2025-06-12 | 144 | View |
| 2025-06-05 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
Latest News on LUNG